NIH researchers have identified the intracellular signalling pathways through which semaglutide and other GLP-1 receptor agonists induce weight loss, revealing why patient responses vary and treatment ...
Genome-wide association studies have linked thousands of genetic variants to disease, yet most remain disconnected from drug-relevant biology. Neville Sanjana, Professor at New York University and ...
Professor Neville Sanjana is a core faculty member at the New York Genome Center and Professor in the Departments of Biology and of Neuroscience and Physiology at New York University. As a bioengineer ...
At AACR 2026, industry leaders discussed how oncology R&D is moving beyond isolated technological advances towards integrated ...
A newly identified protein may explain why some failing hearts recover function following mechanical support while others do ...
Based Models is calling for greater flexibilty from the FDA to accomodate rapidly changing technologies like stem ...
Circio Holding has presented preclinical data at ASGCT demonstrating that its circVec circular RNA platform achieved up to 40 ...
Researchers at the Harrington Discovery Institute have identified cellular mechanisms involving Golgi apparatus proteins that ...
German researchers have developed genESOM, a generative AI system that could reduce animal numbers in preclinical drug ...
Georgetown Lombardi researchers have identified RAGE, an inflammatory receptor, as a key mediator of age-related breast ...
A novel compound developed over 15 years of research has demonstrated unprecedented activity against liver, blood and sexual ...
PORE-cupine, a nanopore-based sequencing method that maps individual RNA structures at single-molecule resolution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results